Talat Imran - 29 Nov 2023 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
Chief Executive Officer, Director
Signature
/s/ Talat Imran
Issuer symbol
RANI
Transactions as of
29 Nov 2023
Net transactions value
+$41,000
Form type
4
Filing time
01 Dec 2023, 08:00:04 UTC
Previous filing
09 Nov 2023
Next filing
06 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RANI Class A Common Stock Purchase $41,000 +20,000 +4.4% $2.05 469,455 29 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.